Onsdag 25 Mars | 13:58:16 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-11-26 08:30 Kvartalsrapport 2026-Q3
2026-08-28 08:30 Kvartalsrapport 2026-Q2
2026-05-28 08:30 Kvartalsrapport 2026-Q1
2026-03-31 N/A X-dag ordinarie utdelning CESSA 0.00 DKK
2026-03-30 N/A Årsstämma
2026-02-27 - Bokslutskommuniké 2025
2025-11-13 - Kvartalsrapport 2025-Q3
2025-08-21 - Kvartalsrapport 2025-Q2
2025-05-15 - Kvartalsrapport 2025-Q1
2025-03-31 - X-dag ordinarie utdelning CESSA 0.00 DKK
2025-03-28 - Årsstämma
2025-02-28 - Bokslutskommuniké 2024
2024-11-13 - Kvartalsrapport 2024-Q3
2024-08-21 - Kvartalsrapport 2024-Q2
2024-05-15 - Kvartalsrapport 2024-Q1
2024-03-28 - X-dag ordinarie utdelning CESSA 0.00 DKK
2024-03-27 - Årsstämma
2024-02-29 - Bokslutskommuniké 2023
2023-11-16 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-12 - Kvartalsrapport 2023-Q1
2023-03-24 - X-dag ordinarie utdelning CESSA 0.00 DKK
2023-03-23 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-18 - Kvartalsrapport 2022-Q3
2022-11-04 - Extra Bolagsstämma 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-04-19 - Kvartalsrapport 2022-Q1
2022-03-18 - X-dag ordinarie utdelning CESSA 0.00 DKK
2022-03-17 - Årsstämma
2022-02-24 - Bokslutskommuniké 2021
2021-11-19 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-04-19 - Kvartalsrapport 2021-Q1
2021-03-29 - X-dag ordinarie utdelning CESSA 0.00 DKK
2021-03-26 - Årsstämma
2021-02-11 - Bokslutskommuniké 2020

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriBioteknik
Cessatech är ett pediatriskt bioteknikbolag som utvecklar specialiserade sjukhusläkemedel för barn, med fokus på ouppfyllda behov med hög effekt inom akut- och akutvård. Bolaget fokuserar på specialprodukter utformade för användning i kliniska miljöer och utvecklar sina program genom en partnerskapsbaserad utvecklingsmodell. Cessatech grundades 2020 och har sitt huvudkontor i Danmark. Bolaget leds av ett team med erfarenhet av läkemedelsutveckling och kommersialisering.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-13 08:30:00

Notice to convene the Annual General Meeting (the "General Meeting") of Cessatech A/S (CVR no. 41 29 30 55) ("Cessatech" or the "Company")

The Board of Directors hereby convenes the Annual General Meeting of Cessatech to be held on:

Monday, 30 March 2026, at 9:00 am (CET)

The General Meeting will be held at the Company's address: Strandvejen 60, 2900 Hellerup, Denmark.

Agenda

  1. Election of Chairman of the meeting
  2. Management's report on the activities of the company in the past financial year
  3. Approval of the audited Annual Report 2025
  4. Resolution on the covering of losses in accordance with the adopted Annual Report 2025
  5. Election of members to the Board of Directors
  6. Election of auditor
  7. Any other business

Complete Proposals

Re 1: Election of chairman of the meeting

The Board of Directors proposes that Mikkel Rostock-Jensen is elected as the Chairman of the General Meeting.

Re 2: Management's report on the activities of the Company in the past financial year

An oral report on the activities of the Company in the past financial year will be presented. The Board of Directors proposes that the report is noted by the General Meeting.

Re 3: Approval of the audited Annual Report 2025

The Board of Directors proposes that the Company's Annual Report with the auditors' report for the financial year 2025 is adopted. The Annual Report is available on the Company's website.

Re 4: Resolution on the covering of losses in accordance with the adopted Annual Report 2025

The Board of Directors proposes that the net loss for the financial year 2025 of tDKK 10,904 be carried forward to the next financial year in accordance with the adopted Annual Report 2025.

Re 5: Election of members to the Board of Directors

The Board of Directors proposes that the following members be re-elected to the Board of Directors: Charlotte Videbæk, Flemming Steen Jensen, Martin Olin and Rachel Curtis Gravesen.

Re 6: Election of auditor

The Board of Directors proposes re-election of PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab, CVR no. 33 77 12 31, as the Company's auditor.

Proxy
The shareholders may vote by proxy for the General Meeting. A proxy and voting correspondence form can be found on the company's website (www.cessatech.com). Voting by proxy may be exercised by completing and returning the proxy and correspondence form by email to info@cessatech.com. Proxies shall be submitted no later than 27 March 2026 before 23.59

Voting by Correspondence
Shareholders may instead of voting in person at the General Meeting choose to vote by mail, i.e. voting in writing prior to the General Meeting. A proxy and voting by correspondence form can be found on the company's website (www.cessatech.com). Any shareholder who wishes to vote by mail shall submit the proxy and voting by correspondence form, duly completed and signed, by email to info@cessatech.com. Votes delivered by mail must be submitted no later than 27 March 2026 before 16.00 and cannot be revoked.

Information
To adopt the proposals under items 1, 3, 4, 5 and 6, a simple majority of the votes cast is required.

The Company's share capital is nominally DKK 3,715,287.40 divided into 18,576,437 shares of nominally DKK 0.20. Each share of nominally DKK 0.20 carries one vote at the General Meeting.

The following documents are available on the Company's website (www.cessatech.com/investor/general-meetings/) and at the Company's registered office from 13 March 2026:

  • Notice to convene the General Meeting
  • Proxy and voting by correspondence form
  • Information on shares and voting rights
  • Annual Report with auditors' report for 2025

A shareholder's right to attend and vote at the General Meeting is determined at the registration date, 23 March 2026, according to the shareholders' register.

Shareholders who are entitled to attend the General Meeting and who wish to attend the General Meeting must request an admission card no later than 27 March 2026 at 23:59 (CET) by email to info@cessatech.com.

The request must be made according to the above guidelines. The shareholder must fill in and sign the proxy and voting by correspondence form.

The shareholders have the right to ask questions in relation to the items on the agenda to be discussed at the General Meeting. The questions can be made in writing before the General Meeting or at the General Meeting.